Silco Pharmaceuticals Limited reported earnings results for the first quarter ended September 30, 2023. For the first quarter, the company reported sales was BDT 102.16 million compared to BDT 129.79 million a year ago. Net income was BDT 10.97 million compared to BDT 29.72 million a year ago.

Basic earnings per share from continuing operations was BDT 0.11 compared to BDT 0.29 a year ago.